{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:46Z","timestamp":1761895186744},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T00:00:00Z","timestamp":1287619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T00:00:00Z","timestamp":1287619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/leu.2010.236","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T09:42:20Z","timestamp":1287654140000},"page":"178-181","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis"],"prefix":"10.1038","volume":"25","author":[{"given":"S","family":"Soverini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Score","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Iacobucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Poerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Colarossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Delledonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Luiselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N C P","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"BFleu2010236_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/leu.2010.56","volume":"24","author":"PA Ho","year":"2010","unstructured":"Ho PA, Alonzo TA, Kopecky KJ, Miller KL, Kuhn J, Zeng R et al. Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Leukemia 2010; 24: 909\u2013913.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/leu.2010.77","volume":"24","author":"A Pardanani","year":"2010","unstructured":"Pardanani A, Lasho TL, Finke CM, Mai M, McClure RF, Tefferi A . IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010; 24: 1146\u20131151.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/leu.2010.52","volume":"24","author":"O Kosmider","year":"2010","unstructured":"Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms. Leukemia 2010; 24: 1094\u20131096.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/leu.2010.113","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A, Lasho TL, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D et al. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 2010; 24: 1302\u20131309.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/leu.2010.98","volume":"24","author":"A Pardanani","year":"2010","unstructured":"Pardanani A, Patnaik MM, Lasho TL, Mai M, Knudson RA, Finke C et al. Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q). Leukemia 2010; 24: 1370\u20131372.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/leu.2010.105","volume":"24","author":"MM Patnaik","year":"2010","unstructured":"Patnaik MM, Lasho TL, Finke CM, Gangat N, Caramazza D, Holtan SG et al. WHO-defined \u2018myelodysplastic syndrome with isolated del(5q)\u2019 in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. Leukemia 2010; 24: 1283\u20131289.","journal-title":"Leukemia"},{"key":"BFleu2010236_CR7","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1182\/blood-2009-07-232595","volume":"114","author":"G Rosti","year":"2009","unstructured":"Rosti G, Palandri F, Castagnetti F, Breccia M, Levato L, Gugliotta G et al. Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia. Blood 2009; 114: 4933\u20134938.","journal-title":"Blood"},{"key":"BFleu2010236_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807\u20131812.","journal-title":"Science"},{"key":"BFleu2010236_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","volume":"116","author":"J Balss","year":"2008","unstructured":"Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A . Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 2008; 116: 597\u2013602.","journal-title":"Acta Neuropathol"},{"key":"BFleu2010236_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/humu.20937","volume":"30","author":"FE Bleeker","year":"2009","unstructured":"Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al. IDH1 mutations at residue p. R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009; 30: 7\u201311.","journal-title":"Hum Mutat"},{"key":"BFleu2010236_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","volume":"118","author":"C Hartmann","year":"2009","unstructured":"Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol 2009; 118: 469\u2013474.","journal-title":"Acta Neuropathol"},{"key":"BFleu2010236_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijc.24379","volume":"125","author":"MR Kang","year":"2009","unstructured":"Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 2009; 125: 353\u2013355.","journal-title":"Int J Cancer"},{"key":"BFleu2010236_CR13","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","volume":"27","author":"M Sanson","year":"2009","unstructured":"Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 2009; 27: 4150\u20134154.","journal-title":"J Clin Oncol"},{"key":"BFleu2010236_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P, Ohgaki H . IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009; 174: 1149\u20131153.","journal-title":"Am J Pathol"},{"key":"BFleu2010236_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765\u2013773.","journal-title":"N Engl J Med"},{"key":"BFleu2010236_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009; 462: 739\u2013744.","journal-title":"Nature"},{"key":"BFleu2010236_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17: 225\u2013234.","journal-title":"Cancer Cell"},{"key":"BFleu2010236_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1203\/00006450-200107000-00015","volume":"50","author":"S Kolker","year":"2001","unstructured":"Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF . Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 2001; 50: 76\u201382.","journal-title":"Pediatr Res"},{"key":"BFleu2010236_CR19","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1046\/j.1460-9568.2003.02639.x","volume":"17","author":"A Latini","year":"2003","unstructured":"Latini A, Scussiato K, Rosa RB, Llesuy S, Bello-Klein A, Dutra-Filho CS et al. D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci 2003; 17: 2017\u20132022.","journal-title":"Eur J Neurosci"},{"key":"BFleu2010236_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1084\/jem.20100523","volume":"207","author":"O Abdel-Wahab","year":"2010","unstructured":"Abdel-Wahab O, Levine RL . Metabolism and the leukemic stem cell. J Exp Med 2010; 207: 677\u2013680.","journal-title":"J Exp Med"},{"key":"BFleu2010236_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058\u20131066.","journal-title":"N Engl J Med"},{"key":"BFleu2010236_CR22","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1200\/JCO.2009.27.3730","volume":"28","author":"G Marcucci","year":"2010","unstructured":"Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrozek K, Margeson D et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 2010; 28: 2348\u20132355.","journal-title":"J Clin Oncol"},{"key":"BFleu2010236_CR23","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1200\/JCO.2009.27.6899","volume":"28","author":"K Wagner","year":"2010","unstructured":"Wagner K, Damm F, Gohring G, Gorlich K, Heuser M, Schafer I et al. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol 2010; 28: 2356\u20132364.","journal-title":"J Clin Oncol"},{"key":"BFleu2010236_CR24","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2009-11-253070","volume":"115","author":"WC Chou","year":"2010","unstructured":"Chou WC, Hou HA, Chen CY, Tang JL, Yao M, Tsay W et al. Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation. Blood 2010; 115: 2749\u20132754.","journal-title":"Blood"},{"key":"BFleu2010236_CR25","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1182\/blood-2009-11-250878","volume":"116","author":"S Abbas","year":"2010","unstructured":"Abbas S, Lugthart S, Kavelaars FG, Schelen A, Koenders J, Zeilemaker A et al. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia (AML): prevalence and prognostic value. Blood 2010; 116: 2122\u20132126.","journal-title":"Blood"},{"key":"BFleu2010236_CR26","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1200\/JCO.2010.28.2285","volume":"28","author":"N Boissel","year":"2010","unstructured":"Boissel N, Nibourel O, Renneville A, Gardin C, Reman O, Contentin N et al. Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: A study by the Acute Leukemia French Association Group. J Clin Oncol 2010; 28: 3717\u20133723.","journal-title":"J Clin Oncol"},{"key":"BFleu2010236_CR27","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","volume":"22","author":"P Paschka","year":"2010","unstructured":"Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Kronke J, Bullinger L et al. IDH1 and IDH2 Mutations Are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 2010; 22: 3636\u20133643.","journal-title":"J Clin Oncol"},{"key":"BFleu2010236_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1182\/blood-2010-03-272146","volume":"116","author":"F Thol","year":"2010","unstructured":"Thol F, Damm F, Wagner K, Gohring G, Schlegelberger B, Hoelzer D et al. Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood 2010; 116: 614\u2013616.","journal-title":"Blood"},{"key":"BFleu2010236_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMc0910063","volume":"362","author":"A Green","year":"2010","unstructured":"Green A, Beer P . Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010; 362: 369\u2013370.","journal-title":"N Engl J Med"},{"key":"BFleu2010236_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","volume":"70","author":"O Abdel-Wahab","year":"2010","unstructured":"Abdel-Wahab O, Manshouri T, Patel J, Harris K, Yao J, Hedvat C et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res 2010; 70: 447\u2013452.","journal-title":"Cancer Res"},{"key":"BFleu2010236_CR31","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3324\/haematol.2010.025494","volume":"95","author":"F Thol","year":"2010","unstructured":"Thol F, Weissinger EM, Krauter J, Wagner K, Damm F, Wichmann M et al. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010; 95: 1668\u20131674.","journal-title":"Haematologica"},{"key":"BFleu2010236_CR32","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","volume":"114","author":"I Iacobucci","year":"2009","unstructured":"Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 2009; 114: 2159\u20132167.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010236","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:35:38Z","timestamp":1648733738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFleu2010236"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.236","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,21]]},"assertion":[{"value":"21 October 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}